AvantGen names Jordon Wang as new COO

San Diego, USA-based biotech AvantGen has appointed of Jordon Wang as its new chief operating officer (COO) and senior vice president of technology development.

Mr Wang will play a pivotal role in driving AvantGen's growth strategies and operational excellence. As the COO, he will focus on expanding AvantGen’s business and technology initiatives, and foster strategic partnerships based on AvantGen’s cutting-edge platforms, the company said.

Mr Wang has over a decade of experience in biologics drug discovery and development. Most recently, he served as VP of technology development and VP of Antibody Discovery at LakePharma, now part of Curia, a global small and large molecule contract research organization (CRO) and CDMO. Prior to LakePharma, Mr Wang led the in vitro pharmacology group at Crown Biosciences and managed a long-term drug discovery collaboration with Pfizer (NYSE: PFE).